🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The effects of treatment with different doses of PEGASYS in combination wit...
Status
Completed
Location
Multiple Locations
Start Date
2004-01
Trial ID
NCT00077649
The rapidly progression of the disease in HIV-HCV co-infected patients just...
Status
Unknown
Location
Hospital General de Alicante
Start Date
2005-11
Trial ID
NCT00611819
Treatments Being Tested
The purpose of this research study is to test the safety, tolerability, and...
Status
Completed
Location
San Diego Gastroenterology Clinic
Start Date
2004-10
Trial ID
NCT00575224
Treatments Being Tested
This is a treatment protocol using IND Ribavirin-there is no control group....
Status
Withdrawn
Location
Landstuhl Regional Medical Center
Start Date
2009-10
Trial ID
NCT00868946
Treatments Being Tested
This sudy will determine whether shortening treatment for hepatitis C is fe...
Status
Completed
Location
Hunter Pharmacotherapy
Start Date
2012-06
Trial ID
NCT01364090
Treatments Being Tested
This 4-arm study will compare the efficacy and safety of PEGASYS induction ...
Status
Completed
Location
Multiple Locations
Start Date
2007-02
Trial ID
NCT00394277
Treatments Being Tested
This is a research study of ribavirin which will be given in combination wi...
Status
Completed
Location
Jewish General Hospital
Start Date
2015-05
Trial ID
NCT02073838
Treatments Being Tested
This is an Australian, open-label, multicenter, randomized, double-blind cl...
Status
Terminated
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00255034
Treatments Being Tested
To learn if giving immune checkpoint therapy (such as atezolizumab) and bev...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2023-03-17
Trial ID
NCT05717400
Treatments Being Tested
This will be a randomized, open-label, active-control Phase II pilot trial ...
Status
Completed
Location
LTD Vakhtang Bochorishvili Anticeptic Centre
Start Date
2011-01
Trial ID
NCT01273948
Treatments Being Tested